Published in Curr Pharm Des on January 01, 2013
Preoperative, postoperative and 1-year follow-up N-terminal pro-B-type natriuretic peptide levels in severe chronic aortic regurgitation: correlations with echocardiographic findings. Interact Cardiovasc Thorac Surg (2008) 1.40
p27Kip1 metabolism: a fascinating labyrinth. Cell Cycle (2007) 1.34
Von Hippel-Lindau-dependent polycythemia is endemic on the island of Ischia: identification of a novel cluster. Blood (2005) 1.26
Resveratrol: from basic science to the clinic. Cell Cycle (2007) 1.23
Genetic basis of congenital erythrocytosis: mutation update and online databases. Hum Mutat (2013) 1.18
p57(Kip2) and cancer: time for a critical appraisal. Mol Cancer Res (2011) 1.13
Targeting p27Kip1 protein: its relevance in the therapy of human cancer. Expert Opin Ther Targets (2011) 1.07
The N-terminal 11 amino acids of human erythrocyte band 3 are critical for aldolase binding and protein phosphorylation: implications for band 3 function. Blood (2005) 1.02
Association of breast cancer and polymorphisms of interleukin-10 and tumor necrosis factor-alpha genes. Clin Chem (2003) 1.00
Inorganic phosphate enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin via a p53-dependent pathway. J Cell Physiol (2013) 0.99
Retinoic acid induces p27Kip1 nuclear accumulation by modulating its phosphorylation. Cancer Res (2006) 0.99
5-Fluorouracil induces apoptosis in rat cardiocytes through intracellular oxidative stress. J Exp Clin Cancer Res (2012) 0.99
Zoledronic acid: an unending tale for an antiresorptive agent. Expert Opin Pharmacother (2010) 0.94
Resveratrol: from basic studies to bedside. Cancer Treat Res (2014) 0.94
In vivo effect of the natural antioxidant hydroxytyrosol on cyclosporine nephrotoxicity in rats. Nephrol Dial Transplant (2007) 0.88
Spectrum of FANCA mutations in Italian Fanconi anemia patients: identification of six novel alleles and phenotypic characterization of the S858R variant. Hum Mutat (2003) 0.88
P27Kip1 serine 10 phosphorylation determines its metabolism and interaction with cyclin-dependent kinases. Cell Cycle (2014) 0.88
Retinoic acid inhibits the growth of bone marrow mesenchymal stem cells and induces p27Kip1 and p16INK4A up-regulation. Mol Cell Biochem (2003) 0.88
The tyrosine kinase inhibitor dasatinib induces a marked adipogenic differentiation of human multipotent mesenchymal stromal cells. PLoS One (2011) 0.87
Change in TNF-alpha receptor expression is a relevant event in doxorubicin-induced H9c2 cardiomyocyte cell death. J Interferon Cytokine Res (2007) 0.86
Congenital dyserythropoietic anemia type II: molecular analysis and expression of the SEC23B gene. Orphanet J Rare Dis (2011) 0.86
EPO receptor gain-of-function causes hereditary polycythemia, alters CD34 cell differentiation and increases circulating endothelial precursors. PLoS One (2010) 0.85
Integrating leptin and cAMP signalling pathways in triple-negative breast cancer cells. Front Biosci (Landmark Ed) (2013) 0.84
Proliferate and survive: cell division cycle and apoptosis in human neuroblastoma. Haematologica (2002) 0.84
p57Kip2 is a downstream effector of BCR-ABL kinase inhibitors in chronic myelogenous leukemia cells. Carcinogenesis (2010) 0.84
Diverse effects of natural antioxidants on cyclosporin cytotoxicity in rat renal tubular cells. Nephrol Dial Transplant (2005) 0.84
Beta-spectrinBari: a truncated beta-chain responsible for dominant hereditary spherocytosis. Haematologica (2009) 0.83
Leptin affects adenylate cyclase activity in H9c2 cardiac cell line: effects of short- and long-term exposure. Am J Hypertens (2002) 0.83
Histone deacetylase inhibitors upregulate p57Kip2 level by enhancing its expression through Sp1 transcription factor. Carcinogenesis (2008) 0.82
Erythropoietin receptors on cancer cells: a still open question. J Clin Oncol (2007) 0.82
The HIF2A gene in familial erythrocytosis. N Engl J Med (2008) 0.82
cAMP Elevation Down-Regulates β3 Integrin and Focal Adhesion Kinase and Inhibits Leptin-Induced Migration of MDA-MB-231 Breast Cancer Cells. Biores Open Access (2012) 0.81
Congenital erythrocytosis associated with gain-of-function HIF2A gene mutations and erythropoietin levels in the normal range. Haematologica (2013) 0.81
Synergistic cytotoxic effects of inorganic phosphate and chemotherapeutic drugs on human osteosarcoma cells. Oncol Rep (2013) 0.80
The possible use of inorganic phosphate in osteosarcoma therapy. Future Oncol (2013) 0.79
Infant hypervitaminosis A causes severe anemia and thrombocytopenia: evidence of a retinol-dependent bone marrow cell growth inhibition. Blood (2002) 0.79
Development and performance analysis of PCL/silica nanocomposites for bone regeneration. J Mater Sci Mater Med (2010) 0.79
Resveratrol and cancer treatment: is hormesis a yet unsolved matter? Curr Pharm Des (2013) 0.78
HNF-1β mutation affects PKD2 and SOCS3 expression causing renal cysts and diabetes in MODY5 kindred. J Nephrol (2013) 0.78
Inorganic Phosphate as a Novel Signaling Molecule with Antiproliferative Action in MDA-MB-231 Breast Cancer Cells. Biores Open Access (2013) 0.78
Genes transcriptionally modulated by interferon alpha2a correlate with the cytokine activity. Haematologica (2004) 0.77
Inorganic phosphate as a signaling molecule: a potential strategy in osteosarcoma treatment. Curr Pharm Des (2013) 0.77
Vitamin A and infancy. Biochemical, functional, and clinical aspects. Vitam Horm (2003) 0.77
Cell division cycle manipulation and cancer treatment: a solid promise or just a dream? Haematologica (2002) 0.75
Development of innovative biopolymers and related composites for bone tissue regeneration: study of their interaction with human osteoprogenitor cells. J Appl Biomater Funct Mater (2012) 0.75